At LSI 2021, Lisa Carmel, VP of Strategy at Ximedica sits down with Benjamin Glenn of A Matter of Innovation to discuss how Ximedica works to guide and nurture new technologies emerging from both early-stage companies and larger strategics, (and everything in between). Lisa talks to Ben about the role of Ximedica within the larger ecosystem of Medtech. Highlights include mentions of Chris Velis's crystal ball predictions from LSI 2020. AMOI Website
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
Lisa has 25+ years of healthcare product commercialization with companies in the US, Europe and China, with a special emphasis on medtech innovation. As an active member of the medtech and investor communities, Lisa is as an advisor to many startups and accelerators including CLSI’s FAST program, Medtech Innovator and UCSF Health Hub. She also serves as an advisor to the Cleveland Clinic Medtech Advisory Board, the Mayo Clinic’s Executive Steering Committee for the Surgical Innovation Summit, UCLA Biodesign, UCLA’s Technology Ventures Group Advisory Board and Red Crow Angel Investor platform. In 2021-22 Lisa serves as Co-Chair of MedtechWomen’s Annual Medtech Vision Conference. Lisa has a keen interest in the latest medtech innovation trends and authors Veranex’ Medtech Pioneers blog, which spotlights medtech leadership and their groundbreaking work.
Lisa has 25+ years of healthcare product commercialization with companies in the US, Europe and China, with a special emphasis on medtech innovation. As an active member of the medtech and investor communities, Lisa is as an advisor to many startups and accelerators including CLSI’s FAST program, Medtech Innovator and UCSF Health Hub. She also serves as an advisor to the Cleveland Clinic Medtech Advisory Board, the Mayo Clinic’s Executive Steering Committee for the Surgical Innovation Summit, UCLA Biodesign, UCLA’s Technology Ventures Group Advisory Board and Red Crow Angel Investor platform. In 2021-22 Lisa serves as Co-Chair of MedtechWomen’s Annual Medtech Vision Conference. Lisa has a keen interest in the latest medtech innovation trends and authors Veranex’ Medtech Pioneers blog, which spotlights medtech leadership and their groundbreaking work.
At LSI 2021, Lisa Carmel, VP of Strategy at Ximedica sits down with Benjamin Glenn of A Matter of Innovation to discuss how Ximedica works to guide and nurture new technologies emerging from both early-stage companies and larger strategics, (and everything in between). Lisa talks to Ben about the role of Ximedica within the larger ecosystem of Medtech. Highlights include mentions of Chris Velis's crystal ball predictions from LSI 2020. AMOI Website
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy